The present invention concerns a topical, cosmetic or pharmaceutical preparation containing a combination of 3 or 4 solar filters comprising: -one or two UVA filters to obtain a critical wavelength >; 370 nm, chosen from among: ( i) - 5, 6, 5, 6-tetraphenyl-3, 3'-(1,4-phenylene)-bis[1, 2, 4]triazine; (ii) 1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybe nzoyl]phenyl]-methanone; (iii) - Butyl Methoxydibenzoylmethane (BMDBM), in a quantity less than 2% by weight with regard to the total weight of said composition; (iv) - Hexyl -[4-(diethylamino)-2- hydroxybenzoyl]benzoate, -2,4-Bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6- (4-methoxyphenyl)-1, 3, 5-triazine = (BEMT), -one or two filters chosen from among UVB filters, except octocrylene, PABA and ethylhexyl methoxycinnamate, said composition also containing a pharmaceutically or cosmetically acceptable excipient.La presente invención se refiere a una preparación tópica, cosmética o farmacéutica que contiene una combinación de 3 o 4 filtros solares que comprende: - uno o dos filtros UVA para obtener una longitud de onda crítica >; 370 nm, seleccionados de entre: i. 5,6,5,6-tetrafenil-3,3´-(1,4-fenilen)-bis [1,2,4]triazina, ii. 1,1'-(1,4-piperazindiil)bis[1-[2-[4-(dietilam ino)-2-hidroxibenzoil]fenil]-metanona iii. Butil metoxidibenzoilmetano (BMDBM), en una cantidad menor a 2% en peso con respecto al peso total de la composición, iv. Hexil 2-[4-(dietilamino)-2-hidroxibenzoil]benzoato, - 2,4-Bis[4-(2-etilhexiloxi)-2-hidroxifenil]-6-(4-metoxifenil)-1,3, 5-triazina = (BEMT),- uno dos filtros seleccionados de entre filtros UVB, excepto octocrileno, PABA y etilhexil metoxicinnamato, la composición también contiene un excipiente farmacéutica o cosméticamente aceptable.